Karen Smith
Fortuna: 216 867 $ al 31/08/2026
Fortuna: 216 867 $ al 31/08/2026
La Dra. Karen L. Smith es directora médica de Emergent BioSolutions, Inc., directora independiente de Antares Pharma, Inc., directora independiente de Sangamo Therapeutics, Inc. y directora independiente de Acceleron Pharma, Inc. Es miembro del Consejo de Administración de Antares Pharma, Inc., Sangamo Therapeutics, Inc. y Acceleron Pharma, Inc. La Dra. Smith trabajó anteriormente como Presidenta y Directora General de Medeor Therapeutics, Inc., Directora General de Eliminate Cancer, Inc., Directora y Vicepresidenta de Celator Pharmaceuticals, Inc, directora no ejecutiva de Forward Pharma A/S, directora médica y vicepresidenta ejecutiva de Investigación y Desarrollo de Jazz Pharmaceuticals Plc, vicepresidenta ejecutiva de Asuntos Médicos Globales y jefa de Dermatología de Allergan, Inc, jefa de Relaciones Médicas Externas de AstraZeneca LP, jefa de Operaciones Clínicas de EE.UU. de Bristol Myers Squibb Co, y directora ejecutiva de Boron Molecular Ltd. También formó parte del consejo de administración de Sucampo Pharmaceuticals, Inc. Se licenció en la Universidad Tecnológica de Curtin, se graduó en la Universidad de Salford, obtuvo un MBA en la Universidad de Nueva Inglaterra (Australia), un doctorado en la Universidad de Warwick y un doctorado en la Universidad de Australia Occidental.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/04/2025 | 12.672 ( 0,01 % ) | 204 146 $ | 31/08/2026 | |
| 20/04/2026 | 77.100 ( 0,02 % ) | 12 722 $ | 31/08/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Miembro de la Junta | 28/06/2018 |
| EMYRIA LIMITED | Director/Miembro de la Junta | 29/11/2021 |
| SKYE BIOSCIENCE, INC. | Director/Miembro de la Junta | 02/07/2024 |
| CONTEXT THERAPEUTICS INC. | Director/Miembro de la Junta | 04/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| TOUE BIOPAR | Director/Miembro de la Junta | 01/10/2023 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Director Técnico/Científico/I+D | 01/09/2023 |
| QUINCE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/09/2023 |
| ANTARES PHARMA, INC. | Director/Miembro de la Junta | 24/05/2022 |
| EMERGENT BIOSOLUTIONS INC. | Director Técnico/Científico/I+D | 01/12/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 31 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.